Efficacy and safety of cyclosporin A ophthalmic emulsion in the treatment of moderate-to-severe dry eye disease: a dose-ranging, randomized trial. The Cyclosporin A Phase 2 Study Group (Q40765221)
scientific article
Language:
Current Data About Efficacy and safety of cyclosporin A ophthalmic emulsion in the treatment of moderate-to-severe dry eye disease: a dose-ranging, randomized trial. The Cyclosporin A Phase 2 Study Group
(P31) (Q13442814)
(P248)
(P698) 10811092
(P813) Saturday, September 23, 2017

(P304) 967-974
(P248)
(P698) 10811092
(P813) Saturday, September 23, 2017

(P433) 5
(P248)
(P698) 10811092
(P813) Saturday, September 23, 2017

(P478) 107
(P248)
(P698) 10811092
(P813) Saturday, September 23, 2017

(P577) Monday, May 1, 2000
(P248)
(P698) 10811092
(P813) Saturday, September 23, 2017

(P921) (Q42824440)

(Q3041498)
(P887)

(Q367700)
(P887)

(P1433) (Q7098109)
(P248)
(P698) 10811092
(P813) Saturday, September 23, 2017

(P1476) "Efficacy and safety of cyclosporin A ophthalmic emulsion in the treatment of moderate-to-severe dry eye disease: a dose-ranging, randomized trial. The Cyclosporin A Phase 2 Study Group" (language: en)
(P248)
(P698) 10811092
(P813) Saturday, September 23, 2017

(P2093) D Stevenson
(P1545) 1
(P248)
(P698) 10811092
(P813) Saturday, September 23, 2017

J Tauber
(P1545) 2
(P248)
(P698) 10811092
(P813) Saturday, September 23, 2017

B L Reis
(P1545) 3
(P248)
(P698) 10811092
(P813) Saturday, September 23, 2017

(P2860) (Q44997732)
(P248)
(P854) https://api.crossref.org/works/10.1016%2FS0161-6420%2800%2900035-X
(P813) Thursday, January 7, 2021
(P887)

(Q39457390)
(P248)
(P854) https://api.crossref.org/works/10.1016%2FS0161-6420%2800%2900035-X
(P813) Thursday, January 7, 2021
(P887)

(Q34369619)
(P248)
(P854) https://api.crossref.org/works/10.1016%2FS0161-6420%2800%2900035-X
(P813) Thursday, January 7, 2021
(P887)

(Q34441489)
(P248)
(P854) https://api.crossref.org/works/10.1016%2FS0161-6420%2800%2900035-X
(P813) Thursday, January 7, 2021
(P887)

(Q41858527)
(P248)
(P854) https://api.crossref.org/works/10.1016%2FS0161-6420%2800%2900035-X
(P813) Thursday, January 7, 2021
(P887)

(Q71833017)
(P248)
(P854) https://api.crossref.org/works/10.1016%2FS0161-6420%2800%2900035-X
(P813) Thursday, January 7, 2021
(P887)

(Q69734017)
(P248)
(P854) https://api.crossref.org/works/10.1016%2FS0161-6420%2800%2900035-X
(P813) Thursday, January 7, 2021
(P887)

(Q33643546)
(P248)
(P854) https://api.crossref.org/works/10.1016%2FS0161-6420%2800%2900035-X
(P813) Thursday, January 7, 2021
(P887)

(Q33997341)
(P248)
(P854) https://api.crossref.org/works/10.1016%2FS0161-6420%2800%2900035-X
(P813) Thursday, January 7, 2021
(P887)

(Q72658445)
(P248)
(P854) https://api.crossref.org/works/10.1016%2FS0161-6420%2800%2900035-X
(P813) Thursday, January 7, 2021
(P887)

(Q71064375)
(P248)
(P854) https://api.crossref.org/works/10.1016%2FS0161-6420%2800%2900035-X
(P813) Thursday, January 7, 2021
(P887)

(Q72418731)
(P248)
(P854) https://api.crossref.org/works/10.1016%2FS0161-6420%2800%2900035-X
(P813) Thursday, January 7, 2021
(P887)

(Q69674155)
(P248)
(P854) https://api.crossref.org/works/10.1016%2FS0161-6420%2800%2900035-X
(P813) Thursday, January 7, 2021
(P887)

(Q43585293)
(P248)
(P854) https://api.crossref.org/works/10.1016%2FS0161-6420%2800%2900035-X
(P813) Thursday, January 7, 2021
(P887)

(Q37433285)
(P248)
(P854) https://api.crossref.org/works/10.1016%2FS0161-6420%2800%2900035-X
(P813) Thursday, January 7, 2021
(P887)

other details
description scientific article

External Links
(P356) 10.1016/S0161-6420(00)00035-X
(P698) 10811092